Dong-A Socio Holdings Co., Ltd. (KRX:000640)
South Korea
· Delayed Price · Currency is KRW 100,100
-700 (-0.69%)
Apr 29, 2026, 3:30 PM KST
Dong-A Socio Holdings Revenue
In the year 2025, Dong-A Socio Holdings had annual revenue of 1.43T KRW with 7.24% growth. Dong-A Socio Holdings had revenue of 371.86B in the quarter ending December 31, 2025, with 7.19% growth.
Revenue
1,429.77B
Revenue Growth
+7.24%
P/S Ratio
0.47
Revenue / Employee
17.23B
Employees
83
Market Cap
668.18B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 1,429.77B | 96.54B | 7.24% |
| Dec 31, 2024 | 1,333.23B | 201.23B | 17.78% |
| Dec 31, 2023 | 1,132.00B | 117.14B | 11.54% |
| Dec 31, 2022 | 1,014.86B | 132.92B | 15.07% |
| Dec 31, 2021 | 881.94B | 98.63B | 12.59% |
| Dec 31, 2020 | Pro | Pro | Pro |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Bukwang Pharmaceutical | 200.71B |
| Shinpoong Pharmaceutical Co.,Ltd | 234.68B |
| JW Pharmaceutical | 775.30B |
| Huons Global | 847.45B |
| Boryung | 1,017.43B |
| Ildong Pharmaceutical | 566.93B |
| EuBiologics | 96.04B |
| Daewoong | 2,068.37B |